Pancreatic Cancer Research

ResearcherKyoto UniversityActive in the last 2 years

Ayaka Ogawa

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5051689375. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2023: 3 papers · 2024: none · 2025: 1 paper

Papers 4

  1. Neoadjuvant chemoradiotherapy using moderately hypofractionated intensity-modulated radiotherapy for borderline resectable pancreatic cancer : Outcomes and pro… Co-author DOI 10.1007/s00066-025-02433-9↗
  2. Potential utility of cone-beam CT-guided adaptive radiotherapy under end-exhalation breath-hold conditions for pancreatic cancer. Co-author DOI 10.1002/acm2.13827↗
  3. Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced … Co-author DOI 10.1186/s13014-023-02288-3↗
  4. Correction: Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for local… Co-author DOI 10.1186/s13014-023-02321-5↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michio Yoshimura · 4 shared papers, 2023–2025 · strength 0.86
  2. Takashi Mizowaki · 4 shared papers, 2023–2025 · strength 0.86
  3. Mitsuhiro Nakamura · 3 shared papers, 2023 · strength 0.65
  4. Ryo Ashida · 3 shared papers, 2023–2025 · strength 0.62
  5. Takahiro Iwai · 3 shared papers, 2023–2025 · strength 0.62
  6. Toshihiko Masui · 1 shared paper, 2025 · strength 0.21
  7. Masashi Kanai · 1 shared paper, 2025 · strength 0.21
  8. Kei Yamane · 1 shared paper, 2025 · strength 0.21
  9. Kazuyuki Nagai · 1 shared paper, 2025 · strength 0.21
  10. Etsuro Hatano · 1 shared paper, 2025 · strength 0.21
  11. Akihisa Fukuda · 1 shared paper, 2025 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.